Zynaxis
Executive Summary
Former SmithKline Beecham executive Martyn Greenacre named president and CEO of the Malvern, Penn.-based biotechnology start-up. Greenacre joins Zynaxis after spending nearly 20 years at SB, including a tenure as chairman of SmithKline Beecham Pharmaceuticals' European operations from 1989 to 1992.